1,5-Diaryl substituted pyrazoles as p38 kinase inhibitors
申请人:Pharmacia Corporation
公开号:US06509361B1
公开(公告)日:2003-01-21
The present invention contemplates 1,5-diaryl-substituted pyrazole compounds that, inter alia, inhibit the activity of p38 MAP kinase. Also contemplated by the invention are processes for the preparation of the contemplated compounds and for the use of a contemplated compound in treating a mammalian host having a p38 kinase- or TNF-mediated disease.